IDEXX Laboratories, Inc. (IDXX)
515.21
-11.86
(-2.25%)
USD |
NASDAQ |
Oct 06, 16:00
515.21
0.00 (0.00%)
After-Hours: 19:41
IDEXX Laboratories Free Cash Flow : 1.233B for June 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.233B |
| March 31, 2026 | 1.064B |
| December 31, 2025 | 1.040B |
| September 30, 2025 | 940.22M |
| June 30, 2025 | 774.34M |
| March 31, 2025 | 837.70M |
| December 31, 2024 | 798.08M |
| September 30, 2024 | 792.60M |
| June 30, 2024 | 838.95M |
| March 31, 2024 | 796.79M |
| December 31, 2023 | 772.88M |
| September 30, 2023 | 679.35M |
| June 30, 2023 | 592.32M |
| March 31, 2023 | 455.24M |
| December 31, 2022 | 383.71M |
| September 30, 2022 | 435.47M |
| June 30, 2022 | 426.35M |
| March 31, 2022 | 601.96M |
| December 31, 2021 | 633.35M |
| September 30, 2021 | 662.32M |
| June 30, 2021 | 694.03M |
| March 31, 2021 | 666.24M |
| December 31, 2020 | 540.19M |
| September 30, 2020 | 445.20M |
| June 30, 2020 | 366.23M |
| Date | Value |
|---|---|
| March 31, 2020 | 285.96M |
| December 31, 2019 | 303.93M |
| September 30, 2019 | 290.24M |
| June 30, 2019 | 274.29M |
| March 31, 2019 | 262.15M |
| December 31, 2018 | 277.15M |
| September 30, 2018 | 280.46M |
| June 30, 2018 | 296.02M |
| March 31, 2018 | 300.12M |
| December 31, 2017 | 296.57M |
| September 30, 2017 | 282.74M |
| June 30, 2017 | 276.41M |
| March 31, 2017 | 276.09M |
| December 31, 2016 | 269.73M |
| September 30, 2016 | 242.94M |
| June 30, 2016 | 211.01M |
| March 31, 2016 | 172.37M |
| December 31, 2015 | 133.44M |
| September 30, 2015 | 84.24M |
| June 30, 2015 | 104.10M |
| March 31, 2015 | 115.44M |
| December 31, 2014 | 175.15M |
| September 30, 2014 | 215.13M |
| June 30, 2014 | 201.41M |
| March 31, 2014 | 189.14M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Neogen Corp. | 31.90M |
| QuidelOrtho Corp. | -211.20M |
| Aspira Women's Health, Inc. | -5.113M |
| VolitionRX Ltd. | -18.86M |
| Lucid Diagnostics, Inc. | -47.18M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 347.16M |
| Cash from Investing (Quarterly) | -25.50M |
| Cash from Financing (Quarterly) | -325.19M |
| Free Cash Flow Per Share (Quarterly) | 4.043 |
| Free Cash Flow to Equity (Quarterly) | 329.99M |
| Free Cash Flow to Firm (Quarterly) | 329.92M |
| Free Cash Flow Yield | 2.99% |